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Pre-ESCRT Step of Endocytosis Pathway Regulates Parkinson’s Disease 
Protein α-Synuclein 
 
Jaime Pérez and Michael Fiske* 
Department of Biology 
Lake Forest College 
Lake Forest, Illinois 60045 
 
Abstract 
 
Parkinson’s disease (PD) is an incurable 
neurodegenerative disorder linked to the accumulation, 
misfolding, and aggregation of the α-synuclein protein 
in midbrain dopaminergic neurons. Enhancing α-
synuclein degradation may be an effective goal for 
future drugs. Strong evidence links the proteasome and 
lysosome as degradation sites for α-synuclein. 
Recently, α-synuclein was found associated with plasma 
membranes and outside of cells, suggesting that α-
synuclein might use the MVB/endocytosis pathway as a 
route to the lysosome. We tested this hypothesis in a S. 
cerevisiae model for PD. In yeast gene deletion strains 
lacking vps34 or vps27 (both involved in the initial pre-
ESCRT step in this pathway), we assessed if α-synuclein 
accumulated, changed cellular localization, and induced 
toxicity. We report three significant findings. Firstly, α-
synuclein altered its cellular localization in both deletion 
strains. Secondly, α-synuclein accumulated in vps34Δ 
cells. Lastly, the absence of either gene had no effect on 
toxicity. Together, our results suggest that the pre-
ESCRT step in the MVB/endosome pathway is involved 
in degrading α-synuclein, although in an unexpectedly 
complex way. 
 
Introduction 
 
Parkinson’s disease (PD) is an incurable neurodegenerative 
disease afflicting four million people worldwide. Classic 
symptoms include resting tremor and muscular rigidity in 
addition to other motor symptoms (Lozano et al. 2005). Lewy 
bodies, which are inclusions of misfolded and accumulated α 
-synuclein, are found in the substantia nigra of PD patients. 
Sufferers experience a loss of dopamine neurons in this area 
of the brain (Lozano et al. 2004; Giasson et al. 1999; 
Spillantini et al. 1998;  Spillantini et al. 1998; Abeliovich et al. 
2000). Misfolding and accumulation of wild-type (WT) α-
synuclein leads to sporadic PD. Six causal genes have been 
identified in familial PD onset: α-synuclein (Polymeropoulos 
et al. 1997), parkin (Kitada et al. 1998), UCH-L1 (Funayama 
et al. 2002), DJ-1 (Bonifati et al. 2003), PINK1 (Valente et al. 
2004), and LRRK2 (Paisan-Ruiz et al. 2004). α-Synuclein’s 
flexible structure may play a role in its propensity to 
aggregate (Eliezer et al. 2001). The protein localizes to pre-
synaptic nerve terminals (Jakes et al. 1994) and binds to 
phospholipid membranes (Davidson et al. 1998). Recently, it 
has been linked to the ER-Golgi pathway (Dixon et al. 2005). 
Additionally, animal models developed PD-like symptoms 
when WT α-synuclein or familial mutants A30P and A53T 
were over expressed (Masliah et al. 2000; Feany and 
Bender 2000; Lasko et al. 2003). 
The past decade has provided tremendous insight 
into the PD field, but some questions on the molecular basis 
of PD remain unanswered. One important question that  
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remains is whether α-synuclein accumulation is the cause of 
PD. A better understanding of the different pathway(s) α-
synuclein is degraded by is essential for developing new 
treatments.  
Studies have shown that proteasome inhibition 
leads to α -synuclein inclusion formation, highlighting it as a 
key component in α -synuclein degradation (Rideout and 
Stefanis 2002; Sawada et al. 2003; Sharma et al. 2006; 
Bedfort et al. 2008). Evidence for α -synuclein degradation 
by the lysosome through either chaperone mediated 
autophagy or macroautophagy is also strong (Lee et al. 
2004; Cuervo et al. 2004; Vogliatzi et al. 2008; Webb et al. 
2003). Therefore, α -synuclein uses autophagy, one of the 
two main pathways to the lysosome. 
Increasing evidence also supports the role of 
endocytosis, the second major route to the lysosome, in α -
synuclein degradation. Firstly, in yeast models with 
knockouts of key endocytosis genes, α -synuclein dependent 
toxicity is observed (Willingham et al. 2003). Secondly, WT 
and the other familial mutant, E46K, localize to the plasma 
membrane in yeasts, linking α -synuclein’s degradation to 
endocytosis (Outeiro and Lindquist 2003). Accumulation of 
phosphorylated α -synuclein was found in C. elegans with 
endocytosis gene knockouts (Kuwahara et al. 2008). Thirdly, 
α-synuclein is found outside the cells in PD patients, and 
experiments showed that this extracellular accumulated α-
synuclein was internalized through the endocytosis pathway 
and eventually degraded by the lysosome (Lee, H. J et al. 
2008).  
ESCRT proteins are important complexes in the 
endocytic pathway because they transport the substrate into 
the lumen of the endosome. Some ESCRT-I, -II, and -III 
proteins have been studied in relation to α-synuclein 
(Alexandra Ayala, Senior Thesis, 2009) while the rest are in 
the process of being studied (Jaime Perez, Senior Thesis, 
2010) (Table 1). The two pre-ESCRT proteins, vps34 and 
vps27, have not been fully analyzed, and their role in α-
synuclein degradation is unknown.  
My hypothesis is that α-synuclein interacts with 
the pre-ESCRT proteins while using the MVB/endosome 
pathway as a route to the lysosome. My model organism is 
S. cerevisiae (budding yeast). Yeasts are useful organisms 
in the study of PD (Dixon et al. 2005; Outeiro and Lindquist 
2003; Willingham et al. 2003, Flower et al. 2007; Sharma et 
al. 2006). The MVB pathway has been conserved from 
yeasts to humans, making our discoveries clinically 
applicable (Katzman et al. 2001). In addition, the yeast 
genome has been sequenced and an entire gene knockout 
library is available for our use (Open Biosystems). In the 
present study, three α -synuclein PD-related properties were 
assessed in genetically compromised yeasts at the pre-
ESCRT step: accumulation, localization, and cell toxicity. We 
report three significant findings. Firstly, α -synuclein altered 
its cellular localization in both deletion strains. Secondly, α -
synuclein accumulated in cells without vps34. Lastly, no α-
synuclein dependent toxicity was observed in either gene 
knockout.  
 
Materials and Methods 
 
Except for the Loss of Induction assay the following methods 
have all been adapted from Sharma et al. (2006) and are 
briefly described.  
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α-Synuclein Constructs  
The vectors used in this study (pYES2.1, GFP, WT α-
synuclein, and the A30P and E46K familial mutants) were 
created as previously described in Sharma et al. (2006). 
 
Yeast Strains  
Parent strain BY4741 (mat a) and MVB knockout strains 
vps27Δ, vps34Δ, vps23Δ, vps37Δ, vps22Δ, vps2Δ, and 
vps32Δ were purchased from Open Biosystems.  
 
Yeast Expression  
α-Synuclein expression plasmid vectors were transformed 
into above budding yeast strains as described in Burke et al. 
(2000). Yeast cells were grown on media lacking uracil (SC-
URA) for selection. Using polymerase-chain reaction (PCR), 
the presence of α -synuclein constructs was confirmed. The 
expression of α -synuclein was regulated using a galactose 
inducible promotor (GAL1) in the pYES2.1 vector. Yeast 
cells were grown overnight in SC-URA glucose (2%) media 
at 30ºC. Cells were washed with water and diluted to 5 x 106 
cells/ml in SC-URA galactose (2%) media to induce 
expression and grown to the time points desired for various 
experiments mentioned below. 
 
Western Analysis  
Cells were grown overnight in 5 ml SC-URA glucose at 
30°C, 200 rpm. They were centrifuged at 1500xg for 5 
minutes at 4°C, and washed three times with 5ml water. 
Cells were then transferred to 25 ml of SC-URA galactose at 
30°C at 200 rpm. At 24 hours, 2.5 x 107 cell density was 
calculated to create cell lysates. Cells were washed with 100 
mM NaN3, solubilized in ESB (electrophoresis sample 
buffer), and small beads were added to break up contents. 
Samples were run on Tris-Glycine gels using SDS 
containing running bugger. SeeBlue was used as the 
molecular weight standard. Gels were transferred to a PVDF 
membrane. Western blot was performed by washing 
membranes with different antibodies using standard 
protocols and detected for alkaline phosphatase activity: 
anti-V5 to detect α-synuclein, and anti-PGK 
(phosphoglycerolkinase) as a loading control.  
 
GFP Microscopy  
Cells were grown overnight in 10 ml SC-URA glucose at 
30°C at 200 rpm. Protein expression was induced with SC-
URA galactose as previously described. After 24 and 48 
hours, 1 ml of culture was pipetted into a 1.5 ml 
microcentrifuge tube and 10 ml cell suspension was pipetted 
onto a slide. Cells were visualized under a Nikon TE2000-U 
fluorescent microscope and images were acquired and 
analyzed using Metamorph 4.0 imaging software.  
 
Growth Curve Analysis  
Cells were grown overnight in 5 ml SC-URA glucose at 
30°C, 200 rpm. They were centrifuged at 1500xg for 5 
minutes at 4°C, and washed three times with 5 ml water. 
Cells were resuspended in 10 ml water and counted. 2.0 x 
106 cell density was inoculated into 25 ml galactose and 
grown in a shaking incubator at 30°C, 200 rpm for 48 hours. 
At specific time points (0, 3, 6, 12, 18. 24, 36 and 48 hours), 
1 ml of culture was removed from each culture and pipetted 
into two cuvetes for duplicate readings. Readings were taken 
using a Hitachi U-2000 Spectrophotometer set at 600 nm.   
 
Spotting 
Cells were grown overnight in 5 ml SC-URA glucose at 
30°C, 200 rpm. They were centrifuged at 1500xg for 5 
minutes at 4°C, and washed three times with 5 ml water. 
Cells were resuspended in 10 ml water and counted. 2.0 x 
107 cell density were placed into a 1.5 ml centrifuge tube 
and centrifuged at 2500 rpm for 5 minutes. Water was 
removed and cells were resuspended in 1 ml of sterile DI 
water. Cells were 5-fold serially diluted into 96-microwell 
plates and spotted on SC-URA glucose and galactose plates 
using a multi-channel pipette. Photographs were taken after 
24 hours of growth for glucose plates and 48 hours for 
galactose plates.  
 
Loss of Induction  
Cells were grown overnight in 5 ml SC-URA glucose at 
30°C, 200 rpm. They were washed twice in 5 ml water. Cells 
were re-suspended in 10 ml water and 4 ml were transferred 
into 46 ml of SC-URA galactose and grown for 24 hours. At 
24 hours, cells were counted and lysates were prepared. 
The culture was then transferred to a 50 ml centrifuge tube, 
washed 3 times with 10 ml water and re-suspended in 15 ml. 
5 ml of culture was transferred to 45 ml of SC-URA glucose. 
Lysates were prepared for galactose 24 hrs, glucose 0 hrs, 
glucose 6 hrs, glucose 12 hrs, and glucose 24 hrs, and 
Western blot analysis was performed as described above.   
 
Statistics  
Western blots, loss of induction blots, and microscopy 
pictures at each time point were repeated twice. Growth 
curves and 3 sets of glucose/galactose spotting were 
repeated three times. Growth curves were averaged and a 
cumulative growth curve was generated. Two-tailed 
distribution, two sample equal variable t-tests were 
performed on all cumulative growth curves using Microsoft 
Excel. Each α-synuclein plasmid vector was compared to the 
parent plasmid. For microscopy, Metamorph 4.0 imaging 
software was used to count 750 DIC cells, and the 
corresponding fluorescent pictures of cells were scored for 
phenotype and percentages were calculated.    
 
Results 
 
Gene deletion yeast strains for individual pre-ESCRT 
complex proteins vps34Δ and vps27Δ were used to analyze 
the role of the MVB/endosome pathway in α-synuclein 
degradation. These strains were compared to the isogenic 
parent strain, BY4741. Five plasmid vectors were used. The 
pYES2.1 parent plasmid and GFP plasmid served as 
controls. The remaining vectors included WT (wild-type) α-
synuclein and two α-synuclein familial mutants (A30P and 
E46K). The three PD-related α-synuclein proprieties 
examined were intracellular localization, toxicity, and 
accumulation. Localization was analyzed through fluorescent 
microscopy. Cellular toxicity was assessed through growth 
curves and five-fold dilution spotting, and Western blot was 
utilized to determine how much α-synuclein accumulated. 
 
α-Synuclein Is Non-Toxic and Binds to Plasma Membranes 
in Endocytosis Intact Yeasts 
The isogenic parent strain was used as a control as 
endocytosis is intact in this yeast strain. As previously shown 
in Sharma et al. (2006), α-synuclein localized to the plasma 
membrane in both WT and the E46K familial mutant by 48 
hours, while the other familial mutant, A30P, localized at the 
cytoplasm at the same time points (Figure 1A). An equal 
amount of WT and E46K α-synuclein was expressed in the 
cells, while A30P was expressed at a lower level (Figure 
1B). Lastly, α-synuclein was not toxic to yeasts. In fact, 
A30P cells grew more rapidly than the controls and other α-
synuclein constructs. 
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Figure 1: α-Synuclein is non toxic and binds to plasma membrane in endocytosis intact yeasts.  A. Microscopy: LEFT- Live cell GFP imaging of 
a-synuclein distribution in BY4741 cells at 24 and 48 hrs. RIGHT- Localization Quantification of 750 cells of each transformed α-synuclein construct in 
BY4741, cells were counted and scored at 24 (top) and 48 hrs (bottom) post-induction for five different florescence localization patterns. B. Expression 
& Accumulation: Western blotting was used to assess the amount of WT and familial mutant α-synuclein present in BY4741 yeast at 24 hrs. C. 
Spotting: Five-fold serially diluted spotting plates for α-synuclein expressed in BY4741 in glucose (non-induced) and galactose (induced) media. D. 
Growth Curve Growth curve using OD600 readings for BY4741 control cells induced for WT, E46K α-synuclein and control GFP. T-tests were 
performed at 18 and 24 hours comparing the α-synuclein vectors to the parent plasmid at the respecting time points, all gave p-values values larger 
than 0.05, except for A30P at 18 and 24 hours. 
α-Synuclein Accumulates in Vps34Δ Without Enhancing 
Toxicity 
Our next goal was to examine how α-synuclein properties 
changed in vps34Δ. In support of our hypothesis, both WT 
and E46K α-synuclein had altered localization at 48 hours 
but not 24 hours.  In vps34Δ, α-Synuclein was membrane 
bound and localized to the cytoplasm at 48 hours when 
compared to parent strain. A30P did not alter its localization 
pattern (Figure 2A). Moreover, WT α-synuclein showed 
increased accumulation in vps34Δ when compared to parent 
strain. The loss of induction assay confirmed these results.  
At 24 hours galactose and 0 hours glucose, vps34Δ 
expressed more WT protein than parent strain (Figure 2B). 
However, the expression of any form of α-synuclein did not 
cause toxicity to the cells when compared to parent plasmid. 
In fact, A30P cells again grew better (Figures 2C & D).  
 
Increased Localization of α-Synuclein to the Cytoplasm in 
Vps27Δ 
Finally, vps27Δ was analyzed to see if all pre-ESCRT 
proteins regulated α-synuclein similarly. Reminiscent of 
vps34Δ, WT and E46K α-synuclein localized weakly to the 
plasma membrane at 48 hours. In contrast, at 48 hours α-
synuclein localized to the cytoplasm and at the plasma 
membrane. Again, A30P remained cytoplasmically localized 
(Figure 3A). WT, A30P, and E46K α-synuclein were 
expressed at similar levels compared to BY4741 (Figure 3B). 
Finally, none of our α-synuclein constructs induced toxicity in 
vps27Δ yeasts (Figures 3C & D). 
 
Discussion 
 
Understanding how α-synuclein is degraded is of significant 
therapeutic value. The field needs more evidence to support 
α-synuclein degradation through the MVB/endosome 
pathway to the lysosome. This paper focused on the pre-
ESCRT protein components of this pathway. We report three  
 
significant findings. Firstly, α-synuclein altered its cellular 
localization in both deletion strains. Secondly, α-synuclein 
accumulated in cells without vps34. Lastly, neither gene 
knockout enhanced α-synuclein dependent toxicity. The  
Eukaryon, Vol. 6, March 2010, Lake Forest College                                                Primary Article 
 
 
 112	  
  
 
 
Figure 2: α-Synuclein accumulates in vps34Δ without enhancing toxicity. A. Microscopy: LEFT- Live cell GFP imaging of α-synuclein distribution 
in vps34Δ cells at 24 and 48 hrs. RIGHT- Localization Quantification of 750 cells of each transformed α-synuclein construct in vps34Δ, cells were 
counted and scored at 24 (top) and 48 hrs (bottom) post-induction for five different florescence localization patterns. B. Expression & Accumulation: 
TOP- Western blot of α-synuclein and GFP alone expression (anti-V5) at 24 hours in BY4741 and vps34Δ lysates.  BOTTOM- Loss of Induction for WT 
α-synuclein in BY4741 and vps34Δ. PGK serves as loading control. C. Spotting: Five-fold serially diluted spotting plates for α-synuclein expressed in 
vps34Δ in glucose (non-induced) and galactose (induced) media. D. Growth Curve: Growth curve using OD600 readings for vps34Δ cells induced for 
WT, E46K α-synuclein and control GFP. T-tests were performed at 18 and 24 hours comparing the α-synuclein vectors to the parent plasmid at the 
respecting time points. WT and E46K gave p-values larger than 0.05. GFP gave p-values of 0.02 and 0.02 at 18 and 24 hours respectively. A30P gave 
p-values of 0.018 for both 18 and 24 hours when compared to parent plasmid. 
 
 
DebBurman lab began evaluating this question in 2008, and 
our study extends this work even further.  
Table 1 summarizes the progress of the work 
conducted on the MVB/endocytosis pathway. More research 
is needed to evaluate how significantly the MVB/endosome 
pathway’s involvement is in α-synuclein degradation. 
 
Compromised Endocytosis Regulates α-Synuclein 
Localization 
We observed a change in localization in vps34Δ and 
vps27Δ, which supported our hypothesis. Studies with 
different yeast compromised for individual ESCRT proteins 
with α-synuclein have shown changes in localization as well 
(Table 1) (Alexandra Ayala, Senior Thesis, 2009; Jaime 
Perez, Senior Thesis, 2010). Previous data shows that 
vps34 is required for protein and membrane trafficking 
events such as MVB formation (Kihara et al. 2001). Vps27 
also mediates endosomal protein sorting through ubiquitin 
attachment (Bilodeau et al. 2002). Since these proteins  
 
mediate such important MVB/endosome cargo components, 
and since α-synuclein is expected to take this 
MVB/endosome pathway for degradation, deleting such 
important genes should change α-synuclein localization. 
 
α-Synuclein Accumulates in Vps34-Compromised Yeasts 
Our second important finding is that WT α-synuclein in 
vps34 accumulated, confirming our hypothesis. On the other 
hand, since no effect on vps27 was noted, our hypothesis 
was refuted (Table 1). Since vps34 and vps27 have roles in 
MVB cargo formation, perhaps vps27 does not play as large 
of a role as vps34 in α-synuclein degradation. Previous 
studies demonstrated that ESCRT-II does not have a 
significant part in endosomal transport (Bowers et al. 2005), 
suggesting that not all the different ESCRT proteins are 
involved in the degradation of α-synuclein. Vps37 is 
responsible for the synthesis of a specific phospholipid, 
phosphatidylinositol 3-phosphate, which then forms a 
complex at the membrane with vps15 to regulate protein 
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Figure 3: Increased localization of α-synuclein to the cytoplasm in vps27Δ. A. Microscopy: LEFT- Live cell GFP imaging of α-synuclein 
distribution in vps27Δ cells at 24 and 48 hrs. RIGHT- Localization Quantification of 750 cells of each transformed α-synuclein construct in vps27Δ, cells 
were counted and scored at 24 (top) and 48 hrs (bottom) post-induction for five different florescence localization patterns. B. Expression & 
Accumulation: LEFT- Western blot of α-synuclein and GFP alone expression (anti-V5) at 24 hours in BY4741 and vps34Δ lysates.  RIGHT- Loss of 
Induction for WT α-synuclein in BY4741 and vps27Δ. PGK serves as loading control. C. Spotting: Five-fold serially diluted spotting plates for α-
synuclein expressed in vps27Δ in glucose (non-induced) and galactose (induced) media. D. Growth Curve: Growth curve using OD600 readings for 
vps27Δ cells induced for WT, E46K α-synuclein and control GFP. T-tests were performed at 18 and 24 hours comparing the α-synuclein vectors to the 
parent plasmid at the respecting time points, all gave p-values values larger than 0.05. 
sorting (Herman & Erm, 1990; Stack et al. 1993). Vps27 on 
the other hand, forms a different complex with Hse1, which 
is a protein required for the recycling of Golgi proteins. The 
vps27-Hse1 complex then aids in lumenal membrane 
formation and ubiquitinated protein sorting (Piper et al. 1995; 
Bilodeau et al. 2002). Impairment of vps34 might have 
prevented creation of this important phospholipid, and 
subsequently, inhibited protein sorting. When this interaction 
was impaired, α-synuclein degradation ceased, and the 
protein accumulated in the cell. In addition, other proteins in 
the ESCRT complex could have compensated for the lack of 
vps27. 
 
A Surprising Absence of Toxicity 
Our final notable finding is the surprising absence of α-
synuclein-dependent toxicity in either strain (Table 1). We 
expected to see cell death or impaired growth due to α- 
synuclein expression based on previous literature. One 
possibility is that the proteosome compensates when the 
MVB/endosome pathway is compromised and clears any 
toxic α-synuclein. Research demonstrates that the opposite 
is true; when the proteasome pathway is impaired, 
autophagy acts as a compensatory system (Pandey 2007). 
Yeasts are quite adept at surviving under harsh 
environmental conditions, and they might have evolved 
protective factors that diminish α-synuclein’s toxicity. Since 
localization shifts to the plasma membrane, perhaps these 
cells need a minimum level of α-synuclein at the plasma 
membrane in order for toxicity to occur. Studies show that α-
synuclein disrupts normal membrane processes that 
eventually lead to toxicity (Volles and Lansbury 2007). 
Lastly, samples in our lab might not be expressing α-
synuclein at high enough concentrations to induce toxicity. 
Studies with different yeast compromised for individual 
ESCRT proteins with α-synuclein have also not exhibited an 
α-synuclein dependent toxicity (Table 1) (Alexandra Ayala, 
Senior Thesis, 2009; Jaime Perez, Senior Thesis, 2010). 
 
Future Studies 
Future studies need to examine the other pre-ESCRT 
proteins such as Hse1. Additionally, examining the post- 
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Strain: 
 
 
Localization 
 
 
Toxicity 
 
 
Accumulation 
 
 
Pre-ESCRT 
vps27Δ 
vps34Δ 
 
 
 
Weak 
Weak 
 
 
Non Toxic 
Non Toxic 
 
 
Strong (WT) 
None 
 
ESCRT-I: 
 
mvb12Δ 
vps23Δ 
vps28Δ 
vps37Δ 
 
 
 
 
None 
Weak 
Weak 
Strong 
 
 
 
Non Toxic 
Non Toxic 
Weak 
Non Toxic 
 
 
 
Weak 
Weak 
Weak 
Strong 
 
ESCRT-II: 
 
vps25Δ 
vps36Δ 
 
 
 
 
Weak 
Weak 
 
 
 
 
Non Toxic 
Non Toxic 
 
 
 
Weak 
Strong 
 
ESCRT-III: 
 
vps20Δ 
vps24Δ 
 
 
 
 
Weak 
Strong 
 
 
 
Non Toxic 
Toxic (A30P) 
 
 
 
Strong 
None 
 
Table 1: Deletion Analysis- Summary of Changes 
 
 
ESCRT proteins and their ability to regulate α-synuclein 
degradation is important because of their role in the 
disassembly and final step of the protein sorting process. 
Other studies could examine the combined effect of two 
ESCRT protein gene deletions with α-synuclein to answer 
whether MVB/endocytosis genes compensate for one 
another. Lastly, it might be beneficial to study combined 
MVB dysfunction with a compromised proteasome. 
 
Conclusion 
 
Currently no treatment for the burden caused by 
neurodegenerative disorders exists. The research being 
done will help our understanding of the mechanism by which 
α-synuclein is removed from PD patients and eventually lead 
to the development of information that will help cure PD and 
similar diseases.  
This study focused on one of the mechanisms by 
which α-synuclein is removed from cells. From the three 
significant findings of this study together, our results suggest 
that the pre-ESCRT step in the MVB/endosome pathway is 
involved in degrading α-synuclein, although in an 
unexpectedly complex way. Results support our hypothesis. 
While all three ESCRT complexes appear to be involved, not 
all of their protein components may be contributing to the 
regulation of α-synuclein degradation.  
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